HSI Seizes 686 Websites Selling Counterfeit Medicine to Unsuspecting Consumers

HSI seizes 686 websites selling counterfeit medicine to unsuspecting consumers

Filed under: Washington D.C. Drug Abuse

Washington, DC – In the largest operation of its kind, 100 countries took part in an international week of action targeting the online sale of counterfeit and illegal medicines. U.S. Immigration and Customs Enforcement's … were believed to contain …
Read more on Imperial Valley News

 

Oregon pot measure struggles as Wash., Colo. thrive

Filed under: Washington D.C. Drug Abuse

The state ranked seventh in the nation for marijuana use among people 12 and older, according to data from the National Survey on Drug Use and Health. Colorado ranked third and Washington 11th. In both those states, lawyers writing the initiatives took …
Read more on McMinnville News-Register

 


 

Prescription Drug Abuse: Health Care Provider Compliance and DEA’s Role – More information on Pharmaceutical and Medical Devices: www.fulbright.com Presenter: Fulbright Healthcare Lawyer Rick Robinson | www.fulbright.com/rrobinson The works with and sometimes against health care providers as it tries to stem the tide of prescription drug abuse. In 2009, the DEA estimated that, on average, 6027 persons per day abused prescription pain relievers for the first time. The Center for Disease Control now attributes more overdose deaths to prescription drugs—including opioids and antidepressants—than to “street drugs” such as cocaine, heroin and amphetamines. The DEA helps health care providers recognize drug abuse and signs of diversion, and relies on their input and due diligence to combat diversion. On the other hand, DEA has aggressively pursued criminal, civil and administrative actions against physicians who facilitate prescription drug abuse and the health care facilities that fail to take required actions to minimize the risk of drug diversion. Stepped-up DEA enforcement makes diversion control a critical compliance risk area for all health care providers. Join us for an informative discussion of the latest DEA initiatives, and learn how your compliance program must account for this heightened risk area. **Most state bar organizations will only allow you to claim self-study CLE credit for watching this recording. Please refer to your state’s CLE rules**

 

Leave a Reply

Your email address will not be published. Required fields are marked *